Bray Capital Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $1.83M | Buy |
4,554
+624
| +16% | +$251K | 0.5% | 56 |
|
|
2024
Q3 | $1.83M | Hold |
3,930
| – | – | 0.45% | 59 |
|
|
2024
Q2 | $1.84M | Hold |
3,930
| – | – | 0.46% | 57 |
|
|
2024
Q1 | $1.64M | Hold |
3,930
| – | – | 0.42% | 61 |
|
|
2023
Q4 | $1.6M | Hold |
3,930
| – | – | 0.44% | 58 |
|
|
2023
Q3 | $1.37M | Hold |
3,930
| – | – | 0.42% | 58 |
|
|
2023
Q2 | $1.38M | Hold |
3,930
| – | – | 0.41% | 61 |
|
|
2023
Q1 | $1.24M | Hold |
3,930
| – | – | 0.36% | 69 |
|
|
2022
Q4 | $1.13M | Hold |
3,930
| – | – | 0.35% | 69 |
|
|
2022
Q3 | $1.14M | Hold |
3,930
| – | – | 0.36% | 68 |
|
|
2022
Q2 | $1.11M | Hold |
3,930
| – | – | 0.33% | 74 |
|
|
2022
Q1 | $1.03M | Hold |
3,930
| – | – | 0.26% | 84 |
|
|
2021
Q4 | $863K | Hold |
3,930
| – | – | 0.21% | 94 |
|
|
2021
Q3 | $713K | Buy |
3,930
+190
| +5% | +$34.5K | 0.18% | 99 |
|
|
2021
Q2 | $754K | Buy |
3,740
+350
| +10% | +$70.6K | 0.19% | 94 |
|
|
2021
Q1 | $728K | Hold |
3,390
| – | – | 0.2% | 92 |
|
|
2020
Q4 | $801K | Buy |
3,390
+865
| +34% | +$204K | 0.23% | 87 |
|
|
2020
Q3 | $687K | Buy |
+2,525
| New | +$687K | 0.24% | 84 |
|